Gut microbiota and type 2 diabetes mellitus.

Area of Science:

• Microbiology
• Metabolic Diseases
• Human Health

Background:

• The gut microbiome is increasingly linked to prevalent diseases, including type 2 diabetes and obesity.
• Obesity is associated with altered gut microbial composition, favoring energy-harvesting microorganisms.
• Microbiota influences insulin resistance and diabetes through mechanisms like altered gut permeability, endotoxemia, and bile acid interactions.

Purpose of the Study:

• To review the relationship between gut microbiome and the development of obesity and type 2 diabetes.
• To explore mechanisms linking gut microbiota to insulin resistance.
• To discuss potential therapeutic strategies for modulating the gut microbiome in metabolic diseases.

Main Methods:

• Literature review of studies investigating the gut microbiome in obesity and type 2 diabetes.
• Analysis of proposed mechanisms connecting gut microbiota to metabolic dysfunction.
• Overview of current and emerging interventions targeting the gut microbiome.

Main Results:

• Gut microbiome alterations are observed in obesity, with a shift towards microbes efficient at energy extraction.
• Several pathways link gut microbiota to insulin resistance, including gut barrier function and metabolic signaling.
• Dietary interventions, probiotics, prebiotics, and microbiota transplantation show potential for therapeutic modulation.

Conclusions:

• The gut microbiome plays a significant role in the pathogenesis of obesity and type 2 diabetes.
• Targeting the gut microbiota offers promising avenues for managing and potentially preventing these metabolic diseases.
• Further research into microbiota modulation strategies is warranted for clinical application.